Concepedia

Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions

Bernardo Cortese, Alfonso Ielasi, Enrico Romagnoli, Attilio Varricchio, Andrea Cuculo, Bruno Loi, Francesco Pisano, Donatella Corrado, Marco Sesana, Luigi La Vecchia,

The American Journal of Cardiology · 2015 · 37 citations · 18 references

DOI

Concepts

References

18

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

European Heart Journal · 2012 · 6.8K citations

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

Gilles Montalescot, Stephen D. Wiviott, Eugene Braunwald et al. · The Lancet · 2009 · 1.1K citations

, , +10

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek et al. · The Lancet · 2014 · 556 citations · Full text

, , +11

Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention

Philippe Gabríel Steg, Stefan James, Robert A. Harrington et al. · Circulation · 2010 · 502 citations